JAMES TRIPPETT: Open Payments
NPI 1366473894 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,117 in 119 payments from 28 companies in 2025. Trend: 2023 $2,486 · 2024 $2,905 · 2025 $3,117
Food & beverage: $3,117
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $567 |
| Amgen Inc. | 15 | $296 |
| AstraZeneca Pharmaceuticals LP | 7 | $272 |
| Renalytix AI, Inc. | 8 | $259 |
| Lilly USA, LLC | 7 | $213 |
| Corcept Therapeutics | 4 | $183 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $177 |
| Abbott Laboratories | 10 | $171 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $152 |
| Dexcom, Inc. | 6 | $122 |
Products named: Ozempic, Wegovy, KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT, AIRSUPRA, Korlym, NEFFY, FREESTYLE LIBRE 3, EVENITY.
Industry payments across TX — which companies pay providers there.
